A BuiltForAI Property
Live data · NADAC + Part D CY24 · reviewed daily

Furosemide Injection (FUROSCIX)

Furosemide Injection removes excess fluid by acting on the kidneys, used in heart failure and edema.

First FDA approval2022-11-14
Generic availableNo (brand-only)
Shortage statusNone
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one
Lowest NADAC
/unit
0 NDCs benchmarked, lowest of all strengths.
Average NADAC
Across all dosage forms in distribution.
Highest NADAC
Range is tight.
Plans with PA
0 / 329
Zero PA friction — switching is purely formulary.

Questions a plan sponsor actually asks.

FAQPage schema9 entries indexed · 4 visible
What is Furosemide Injection used for?

Furosemide Injection removes excess fluid by acting on the kidneys, used in heart failure and edema.

Is there a generic for Furosemide Injection?

No. Furosemide Injection is brand-only with no generic equivalents currently in market.

How much does my plan pay for Furosemide Injection?

NADAC pricing data not currently available for this drug.

Is Furosemide Injection on the FDA shortage list?

No. Furosemide Injection is not currently on the FDA Drug Shortage Database.

5 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Same class. Different math.

Loop Diuretic4 alternatives in D1
01
Bumetanide
Brand: Bumex
$0.115Lowest NADAC
19Generic mfrs
$116.6MCY24 Part D spend
Compare →
02
Ethacrynic Acid
Brand: EDECRIN
$0.816Lowest NADAC
7Generic mfrs
$9.3MCY24 Part D spend
Compare →
03
Furosemide
Brand: LASIX ONYU
$0.027Lowest NADAC
21Generic mfrs
$231.6MCY24 Part D spend
Compare →
04
Torsemide
Brand: SOAANZ
$0.063Lowest NADAC
6Generic mfrs
$90.6MCY24 Part D spend
Compare →

Sources · every number above traces back.

Last refresh30 May 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book · NADAC unit costs: CMS NADAC weekly file · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.